Additionally, it could reduce the invasion and metastasis of MDA-MB-231 breast cancer cells by suppressing the expression of matrix metallopeptidase 2 (MMP-2) and matrix metallopeptidase 9 (MMP-9). The gene discussed is MMP9; the disease is breast carcinoma.